The U.S. District Court Judge has ordered a Stipulation of Dismissal for the patent infringement case between InteliFUSE and Biomedical Enterprises following a settlement for an undisclosed amount, according to a company news release.
InteliFUSE, a New Orleans-based orthopedic surgical device manufacturer that markets StimuLINK, accused Biomedical Enterprises of patent infringement. Under the settlement, the InteliFUSE patents under question were acknowledged as valid and enforceable patents.
The StimuLINK is a shape memory mini-implant designed for use in many orthopedic indications, including surgeries of the foot, ankle, hand and wrist. The device replaces plates, screws, rods, nails and wires.
Read the InteliFUSE news release on the patent infringement settlement.
Read other coverage on patent infringement cases:
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
- Stryker Files Patent Infringement Lawsuit Against Zimmer Holdings
- NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement
InteliFUSE, a New Orleans-based orthopedic surgical device manufacturer that markets StimuLINK, accused Biomedical Enterprises of patent infringement. Under the settlement, the InteliFUSE patents under question were acknowledged as valid and enforceable patents.
The StimuLINK is a shape memory mini-implant designed for use in many orthopedic indications, including surgeries of the foot, ankle, hand and wrist. The device replaces plates, screws, rods, nails and wires.
Read the InteliFUSE news release on the patent infringement settlement.
Read other coverage on patent infringement cases:
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
- Stryker Files Patent Infringement Lawsuit Against Zimmer Holdings
- NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement